Novo Nordisk, Pharmacy Reach Agreement In Suit Over Compounded Semaglutide Drugs
HOUSTON — Novo Nordisk Inc. and a compounding pharmacy accused of selling unlicensed compounded drugs that contain semaglutide have reached a settlement agreement in Texas federal court under which the pharmacy...To view the full article, register now.
Already a subscriber? Click here to view full article